Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target
{{output}}
To the Editor COVID-19 (COrona VIrus Disease) patients with cardiovascular (CV) disease, multiple CV risk factors or comorbidities (i.e., arterial hypertension and diabetes) were shown to be more prone to a worse prognosis. SARS-CoV-2 is a still unknown enemy ... ...
